Tobias Herold Selected Research

Tobias Herold Research Topics

Disease

28	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 12/2012
20	Neoplasms (Cancer) 11/2023 - 11/2005
10	Leukemia 01/2023 - 09/2013
5	COVID-19 01/2022 - 01/2020
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 07/2011
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2022 - 01/2020
2	Myeloid Leukemia (Leukemia, Myelocytic) 08/2022 - 12/2021
2	Respiratory Insufficiency (Respiratory Failure) 07/2021 - 07/2020
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2021 - 01/2020
2	Hematologic Neoplasms (Hematological Malignancy) 10/2020 - 12/2014
2	Disease Progression 01/2020 - 01/2018
2	Hypoxia (Hypoxemia) 12/2015 - 07/2015
1	Hemorrhage 01/2022
1	Acute Megakaryoblastic Leukemia (Leukemia, Megakaryocytic) 01/2022
1	Lymphoma (Lymphomas) 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Inflammation (Inflammations) 07/2020
1	Residual Neoplasm 01/2020
1	Migraine Disorders (Migraine) 12/2019
1	Pathologic Complete Response 01/2018
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2018
1	Carcinogenesis 01/2016
1	Aneuploidy (Aneuploid) 01/2016

Drug/Important Bio-Agent (IBA)

5	RNA (Ribonucleic Acid)IBA 05/2024 - 01/2019
4	Oxygen (Dioxygen)IBA 01/2022 - 07/2015
2	ProteomeIBA 01/2023 - 12/2022
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2023 - 01/2014
2	venetoclaxIBA 12/2022 - 01/2019
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2022 - 12/2021
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2020
2	Rituximab (Mabthera)FDA Link 01/2022 - 01/2012
2	Long Noncoding RNAIBA 01/2022 - 09/2020
2	Transcription Factors (Transcription Factor)IBA 12/2021 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2013
2	RNA Splicing FactorsIBA 10/2020 - 01/2020
2	Core Binding Factors (Core-Binding Factor)IBA 01/2020 - 09/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 12/2012
1	Chimeric Antigen ReceptorsIBA 11/2023
1	ADAM10 ProteinIBA 01/2023
1	fms-Like Tyrosine Kinase 3IBA 01/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2023
1	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2022
1	AntibodiesIBA 01/2022
1	magrolimabIBA 01/2022
1	isocitric acid (isocitrate)IBA 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	Leukocyte Immunoglobulin-like Receptor B1IBA 01/2022
1	AlbuminsIBA 01/2022
1	EpitopesIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2022
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2022
1	EnzymesIBA 01/2021
1	olaparibIBA 01/2021
1	Myeloid Cell Leukemia Sequence 1 ProteinIBA 01/2021
1	histone H3 trimethyl Lys4IBA 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021
1	5-hydroxymethylcytosineIBA 01/2021
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2021
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 09/2020
1	Interleukin-6 (Interleukin 6)IBA 07/2020
1	CreatinineIBA 07/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 07/2020
1	NucleosidesIBA 01/2020
1	ProdrugsIBA 01/2020
1	nelarabine (506U78)FDA Link 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	ibrutinibIBA 01/2020
1	GTP-Binding Proteins (G-Protein)IBA 12/2019
1	Calcitonin Receptors (Calcitonin Receptor)IBA 12/2019
1	Neuropeptide Receptors (Neuropeptide Receptor)IBA 12/2019
1	Azacitidine (5 Azacytidine)FDA Link 01/2019
1	Tyrosine (L-Tyrosine)FDA Link 01/2019
1	CCAAT-Enhancer-Binding ProteinsIBA 10/2018
1	InflammasomesIBA 11/2016
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 11/2016
1	Complement System Proteins (Complement)IBA 11/2016
1	Type I Tumor Necrosis Factor ReceptorsIBA 11/2016
1	NucleotidesIBA 01/2016
1	Poly(amidoamine)IBA 01/2016
1	flt3 ligand protein (flt3 ligand)IBA 01/2016
1	Interleukin-8 (Interleukin 8)IBA 12/2015
1	CytokinesIBA 12/2015
1	OTS167IBA 12/2014

Therapy/Procedure

10	Therapeutics 01/2023 - 12/2014
5	Drug Therapy (Chemotherapy) 01/2023 - 07/2015
2	Artificial Respiration (Mechanical Ventilation) 07/2021 - 07/2020
1	Investigational Therapies (Experimental Therapy) 05/2023
1	Combination Drug Therapy (Combination Chemotherapy) 12/2022
1	Immunotherapy 01/2022
1	Cell Transplantation 01/2022
1	Critical Care (Surgical Intensive Care) 01/2020
1	Extracorporeal Membrane Oxygenation 01/2018
1	Induction Chemotherapy 01/2018